Latest news for Li-Metal (OTC:LIMFF) Stock

Li-Metal Corp is a Canada-based company developing lithium metal and anode technologies to provide a low-cost and environmentally friendly solution for next-generation lithium batteries. The company's geographic segments include Canada and the US.

News

Penny Stocks

Market-Moving Exclusives

Exclusives

Markets

General

LIMFF

Li-Metal Corp (OTC: LIMFF) has announced it was granted its first patent by the Canadian Intellectual Property Office (CIPO).

What Happened: Li-Metal has 32 additional patent applications filed.

EXCLUSIVE: Li-Metal Granted First Patent For Production Of Refined Lithium Metal

CSE:LIM

Li-Metal Corp. (CSE:LIM) (OTCQB: LIMFF), a developer of technologies for electric vehicle batteries, announced on Tuesday that it had entered into an exclusive agreement with Mustang Vacuum Systems, Inc (MVS) to advance its ascent into the production of batteries anodes.

EXCLUSIVE: Lithium Producer Li-Metal Advances Ascent Into Electric Battery Anode Production With Partnership

Toronto-based Li-Metal Corp (OTC:LIMFF)(CSE:LIM), a developer of lithium metal anode and lithium metal technologies, has been approved to trade in the United States on the OTC Pink Market, a U.S. trading platform that is operated by the OTC Markets Group in New York.

EXCLUSIVE: Li-Metal Announces Trading On The OTC And DTC Eligibility

Li-Metal Corp

In the latest episode of the Trade To Black podcast, South Carolina Congresswoman Nancy Mace (R) joined hosts Shadd Dales and Anthony Varrell to discuss key issues affecting the cannabis industry, including the recent Democratic National Convention (DNC), the ongoing push for cannabis reform, and the increasing role of <a href="https://www.benzinga.com/topic/hemp">hemp in the U.S. economy.</a>
<h3 class="wp-block-heading">DNC And Cannabis: A Missed Opportunity?</h3>
Mace didn&#8217;t mince words when discussing the DNC, criticizing the lack of tangible progress on cannabis reform despite campaign promises. 
See Also<a href="https://www.benzinga.com/markets/cannabis/22/05/26921758/a-chat-with-rep-nancy-mace-the-south-carolina-republican-behind-the-largest-cannabis-legalizatio">: A Chat With Rep. Nancy Mace: The South Carolina Republican Behind The Largest Ever Cannabis Legalization Bill In The US</a>
"They ran on a platform of being pro-cannabis, pro-marijuana, [but] they really haven&#8217;t done anything to progress the movement," she said. 
Mace suggested that the Biden administration might attempt to reschedule cannabis as a last-minute effort to win over voters.
&#8220;Legislatively, they just haven&#8217;t done anything,&#8221; Mace added, mentioning her own State's Reform Act as a more comprehensive solution.
<h3 class="wp-block-heading">Trump's Stance And GOP's Reluctance</h3>
When asked about former President Donald Trump's stance on cannabis, Mace raised doubts about whether he would address the issue during the upcoming election. 
She noted that Trump has previously supported medical cannabis, which could be significant in states like Florida where such programs are already in place. 
&#8220;It&#8217;s wildly popular in my very conservative red state of South Carolina,&#8221; Mace said, pointing out that a majority of South Carolinians support both medical and recreational cannabis.
On the broader GOP view, Mace acknowledged a reluctance within her party to fully embrace cannabis reform, attributing it to both a generational divide and fears of political backlash. 
&#8220;People are afraid of being primaried,&#8221; she explained, suggesting that some Republicans might be out of touch with the growing public support for cannabis. 
Furthermore, Mace encouraged advocates to bring data to lawmakers, which she believes could help change their perspectives.
<h3 class="wp-block-heading">The Role Of Hemp In South Carolina's Economy</h3>
The discussion also covered the role of hemp, which Mace pointed out as a vital part of South Carolina's economy. She explained that hemp offers Republicans a way to support an agricultural industry without fully endorsing THC-rich cannabis. 
&#8220;They&#8217;re the same plant, right, with different levels of THC,&#8221; Mace noted. She also stressed the importance of keeping taxes low on both hemp and cannabis to avoid fueling black markets, a problem that has plagued states with high cannabis taxes.
As the conversation wrapped up, Mace touched on the potential impact of cannabis rescheduling on political attitudes in Washington. She said rescheduling could provide cover for politicians who are hesitant to back cannabis reform.
&#8220;I think it gives them cover to actually look at it differently,&#8221; Mace concluded.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Congresswoman Nancy Mace Explains Her Stance On Hemp" width="500" height="281" src="https://www.youtube.com/embed/qW95ZAf5q-E?start=33&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39850871/bipartisan-lawmakers-target-marijuana-rescheduling-restriction">Bipartisan Lawmakers Target Marijuana Rescheduling Restriction</a></li>
</ul>

Cannabis

Government

Politics

Legal

GOP Congress Member Nancy Mace: 'They Haven't Done Anything,' Slams DNC Cannabis Inaction, Calls Out Republican Reluctance

The use of songs by Donald Trump on the 2024 election campaign trail has become a contentious point for many bands and artists who don't want to be associated with the former president. Trump's team is fighting back against the Foo Fighters, who were the <a href="https://www.benzinga.com/general/entertainment/24/08/40564358/trump-vs-foo-fighters-former-president-uses-song-my-hero-at-rally-without-permission-band-p">latest to speak out.</a>
 What Happened: At <a href="https://www.benzinga.com/topic/2024-election">a 2024 election </a>rally, which featured surprise guest Robert F. Kennedy Jr., Trump's team played "My Hero," a song by rock band Foo Fighters.
As Benzinga reported, the band spoke out that they did not grant permission for the former president to use the song.
"It's Times Like These facts matter, don't be a Pretender," Trump's rep Steven Cheung wrote in a post on social media platform X, as reported by <a href="https://deadline.com/2024/08/trump-foo-fighters-dispute-rally-music-1236050630/">Deadline</a>.
The tweet claps back at the band by using the titles of two of their songs in "Times Like These" and "The Pretender."
Trump's team said they licensed the song and others through BMI, a music rights company.
"We have a license to play the song," Cheung added.
While Trump's team is clapping back at having the rights to the song, it's worth pointing out that the Foo Fighters said they would pay any royalties obtained for the song from Trump as donations to the Kamala Harris campaign for president.
<a href="https://www.benzinga.com/general/politics/24/07/39895553/trump-vs-harris-former-president-once-donated-to-her-california-ag-campaign-arranged-by-ivanka-w">Benzinga previously shared</a> that Trump made donations to Harris when she was running for attorney general of California in 2011 and 2013. Harris later made a donation for the same amount to a nonprofit organization.
Trump supporters may not like to hear the former president is paying to use songs and that money is going to Harris.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent082724">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: Many artists, <a href="https://www.benzinga.com/general/entertainment/24/08/40327222/trump-hits-iceberg-celine-dion-sony-say-use-of-titanic-theme-song-will-not-go-on">including Celine Dion recently,</a> have spoken out about Trump using their songs at campaign rallies and events without permission. The ire comes as many times bands&#8217; songs are licensable through third-party agencies like BMI.
The Rolling Stones threatened to sue Trump in 2020 for using their "You Can't Always Get What You Want" song at campaign events. The band and other musicians submitted a letter with the Artist Rights Alliance that called for political parties to seek consent before publicly using music in a campaign setting.
The family of late musician Isaac Hayes has been in a battle with Trump over the use of the song "Hold on, I'm Coming," which Hayes co-wrote, at several events including a National Rifle Association (NRA) rally.
That battle between Trump's team and the family has reached the point of a courtroom with an emergency hearing now scheduled for Sept. 3 in Atlanta, as <a href="https://www.hollywoodreporter.com/news/general-news/trump-isaac-hayes-emergency-injunction-unauthorized-use-of-music-1235984524/">reported </a>by The Hollywood Reporter.
The musician's family recently sent a copyright infringement letter to Trump's team in the multi-year battle.
Hayes' family demanded Trump stop playing the song, remove any videos that contain the song, make a public statement and pay $3 million in licensing fees, according to reports.
Along with Trump and his presidential campaign, the complaint also names Turning Point USA, the NRA and the Republican National Committee. Representatives for those parties may also have to appear in court on Sept. 3 for the initial hearing.
The hearing and subsequent rulings in the battle of Trump vs. Hayes' family could quickly change which songs are used at future political rallies.
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent082724">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Photo: Sir. David via Shutterstock

Entertainment

Trump Donates To Harris 2024 Election Campaign By Using Foo Fighters Song, Former President Could Go To Court About Another Song Use At NRA Rally

Roth MKM analyst Benjamin Paluch initiates coverage on CG Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGON#NASDAQ">CGON</a>) with a Buy rating and announces Price Target of $65.

Price Target

Initiation

Analyst Ratings

CGON

Roth MKM Initiates Coverage On CG Oncology with Buy Rating, Announces Price Target of $65

Roth MKM analyst Benjamin Paluch initiates coverage on Replimune Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REPL#NASDAQ">REPL</a>) with a Buy rating and announces Price Target of $17.

REPL

Roth MKM Initiates Coverage On Replimune Group with Buy Rating, Announces Price Target of $17

Ukraine started <a href="https://www.benzinga.com/etfs/specialty-etfs/24/08/40511434/zelenskyy-announces-capture-of-another-russian-village-as-ukraine-pushes-deeper-into-kursk">using F-16 warplanes</a> in combat as Russia mounted a massive aerial assault on civilian infrastructure, according to a U.S. official.
F-16s are the most sophisticated weapon that the U.S.-led coalition has supplied Ukraine in its war with Russia. 
The White House and Pentagon had initially held off on providing them, concerned that Russian President Vladimir Putin would view the act as escalation of the war, USA Today <a href="https://www.usatoday.com/story/news/world/2024/08/27/ukrainian-f-16-warplanes-russia/74965858007/">reported</a>.
U.S. allies supplied the fighter jets, and Ukrainian pilots have trained for months in the U.S. to fly them. The first F-16s arrived in Ukraine early in August.
The official who confirmed their use in combat was not authorized to speak publicly.
Read Also: <a href="https://www.benzinga.com/news/global/24/08/40561938/russia-launches-one-of-the-heaviest-strikes-on-ukraine-in-over-30-months-of-war-zelensky">Russia Launches &#8216;One Of The Heaviest Strikes&#8217; On Ukraine In Over 30 Months Of War: Zelenskyy</a>
The jets can defend Ukrainian airspace from Russian incursions by shooting down drones and missiles and providing support for troops on the ground.
In the last few days, Russia has been hitting Ukrainian power stations with some of the largest barrages of missiles and glide bombs since the war began in February 2022.
The Biden administration agreed to supply Ukraine with F-16s last year after pleas from Ukrainian President Volodymyr Zelenskyy, whose pilots have been flying inferior Soviet-era warplanes.
The White House and Pentagon repeatedly resisted requests for advanced weaponry over fears that their use against Russia would provoke Putin to widen the war, but that has not happened since the Pentagon has supplied long-range, rocket artillery and its&nbsp;main battle tank, the Abrams.
Price Action: Lockheed Martin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), which makes the F-16 Fighting Falcon, gained 0.52% to close at $560.41 on Tuesday.
Read Now:
<ul>
<li><a href="https://www.benzinga.com/government/24/08/40352731/russia-strikes-back-at-ukraines-ground-incursion-into-kursk">Russia Strikes Back At Ukraine&#8217;s Ground Incursion Into Kursk</a></li>
</ul>
Photo: F-16 via Lockheed Martin&#8217;s<a href="https://www.flickr.com/photos/lockheedmartin/albums/72157601438408151/with/1115741330/"> Flickr page</a>

Global

Ukrainian Pilots Begin Using F-16s Against Russia

Wells Fargo analyst Brandon Couillard initiates coverage on Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) with a Overweight rating and announces Price Target of $157.

Wells Fargo Initiates Coverage On Agilent Technologies with Overweight Rating, Announces Price Target of $157

Wells Fargo analyst Brandon Couillard initiates coverage on Thermo Fisher Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) with a Overweight rating and announces Price Target of $670.

Wells Fargo Initiates Coverage On Thermo Fisher Scientific with Overweight Rating, Announces Price Target of $670

Wells Fargo analyst Brandon Couillard initiates coverage on Myriad Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>) with a Overweight rating and announces Price Target of $35.

MYGN

Wells Fargo Initiates Coverage On Myriad Genetics with Overweight Rating, Announces Price Target of $35

Wells Fargo analyst Brandon Couillard initiates coverage on Exact Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXAS#NASDAQ">EXAS</a>) with a Overweight rating and announces Price Target of $75.

EXAS

Wells Fargo Initiates Coverage On Exact Sciences with Overweight Rating, Announces Price Target of $75

Wells Fargo analyst Brandon Couillard initiates coverage on Avantor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVTR#NYSE">AVTR</a>) with a Overweight rating and announces Price Target of $30.

AVTR

Wells Fargo Initiates Coverage On Avantor with Overweight Rating, Announces Price Target of $30

Wells Fargo analyst Brandon Couillard initiates coverage on Bruker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRKR#NASDAQ">BRKR</a>) with a Overweight rating and announces Price Target of $78.

BRKR

Wells Fargo Initiates Coverage On Bruker with Overweight Rating, Announces Price Target of $78

Wells Fargo analyst Brandon Couillard initiates coverage on Repligen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGEN#NASDAQ">RGEN</a>) with a Overweight rating and announces Price Target of $180.

RGEN

Wells Fargo Initiates Coverage On Repligen with Overweight Rating, Announces Price Target of $180

Wells Fargo analyst Brandon Couillard initiates coverage on Maravai LifeSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVI#NASDAQ">MRVI</a>) with a Overweight rating and announces Price Target of $10.

MRVI

Wells Fargo Initiates Coverage On Maravai LifeSciences with Overweight Rating, Announces Price Target of $10

Wells Fargo analyst Brandon Couillard initiates coverage on Mesa Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLAB#NASDAQ">MLAB</a>) with a Underweight rating and announces Price Target of $120.

MLAB

Wells Fargo Initiates Coverage On Mesa Laboratories with Underweight Rating, Announces Price Target of $120

Editor&#8217;s Note: A key point in this article has been updated to reflect accurate information on GameStop&#8217;s peak May 14 share price.
GameStop Corp.&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) second <a href="https://www.benzinga.com/news/24/05/38801786/gamestop-trader-roaring-kitty-sparks-wall-street-rally-in-heavily-shorted-stocks-what-you-need-to-kn">meme stock surge</a> this spring hasn't attracted the swarm of retail investors that made the company famous in 2021, according to trade data released Monday by the Securities and Exchange Commission.
Retail participation in GameStop was roughly half what it was during the original frenzy in January 2021, judging by odd lot volume as a percentage of all volume during the May rally, according to the SEC trade data released on Tuesday, Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-08-27/gamestop-s-may-meme-revival-saw-dropoff-in-retail-participation?srnd=homepage-americas&amp;embedded-checkout=true&amp;sref=TBDibEcD">reported</a>.
 Odd lots, or trades of less than 100 shares, can serve as a rough proxy for retail participation since individual investors typically trade smaller quantities, while institutional investors tend to trade in round lots, which are orders divisible by 100.
GameStop shares surged in May, rising from $10.91 on May 1 to a high of $64.83 on May 14, after &#8220;Roaring Kitty,&#8221; also known as Keith Gill—the social media persona credited with sparking the 2021 meme stock trading frenzy—posted about GameStop on X <a href="https://www.benzinga.com/general/education/24/05/38793704/who-is-roaring-kitty-why-does-his-return-to-social-media-matter-for-gamestop-stock">following a three-year hiatus.</a>
Read Also: <a href="https://www.benzinga.com/news/24/05/38789404/gamestops-rally-resumes-in-may-what-sparked-the-interest">GameStop&#8217;s Rally Resumes In May &#8211; What Sparked The Interest?</a>
In the May 14 post, Gill shared a drawing depicting a man leaning forward in a chair, a widely recognized meme among gamers signaling heightened intensity or seriousness.
GameStop shares went as high as $120.75 in January 2021 after Gill's Reddit posts in the&nbsp;Wallstreetbets group boasted about his profits from investing in GameStop.
The rally had spread to highly shorted stocks, including&nbsp;AMC Entertainment Holdings&nbsp;Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) as Reddit users joined forces to squeeze hedge funds who bet against GameStop and other companies.
Roaring Kitty sparked a frenzy among day traders, who rallied to invest heavily in GameStop stocks and call options from 2020 to 2021.&nbsp;
This collective action caused a short squeeze, resulting in GameStop shares skyrocketing by 1,700% during the 2021 price surge.
Price Action: GameStop declined 2.90% to close at $20.74 on Tuesday.
Read Now:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/05/39043258/gamestop-rally-returns-after-share-offering-how-will-company-use-1-billion-in-proceeds">GameStop Rally Returns After Share Offering: How Will Company Use $1 Billion In Proceeds?</a></li>
</ul>
Photo: Shutterstock

GameStop's Second Meme Surge Fails To Draw 2021's Retail Investor Crowd, SEC Data Shows (CORRECTED)

Wells Fargo analyst Brandon Couillard initiates coverage on CareDx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNA#NASDAQ">CDNA</a>) with a Underweight rating and announces Price Target of $28.

CDNA

Wells Fargo Initiates Coverage On CareDx with Underweight Rating, Announces Price Target of $28

Wells Fargo analyst Brandon Couillard initiates coverage on Bio-Rad Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIO#NYSE">BIO</a>) with a Equal-Weight rating and announces Price Target of $340.

Wells Fargo Initiates Coverage On Bio-Rad Laboratories with Equal-Weight Rating, Announces Price Target of $340

Wells Fargo analyst Brandon Couillard initiates coverage on GeneDx Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGS#NASDAQ">WGS</a>) with a Equal-Weight rating and announces Price Target of $34.

Wells Fargo Initiates Coverage On GeneDx Hldgs with Equal-Weight Rating, Announces Price Target of $34

Wells Fargo analyst Brandon Couillard initiates coverage on Revvity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVTY#NYSE">RVTY</a>) with a Equal-Weight rating and announces Price Target of $130.

RVTY

Wells Fargo Initiates Coverage On Revvity with Equal-Weight Rating, Announces Price Target of $130

Wells Fargo analyst Brandon Couillard initiates coverage on Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) with a Equal-Weight rating and announces Price Target of $280.

Wells Fargo Initiates Coverage On Danaher with Equal-Weight Rating, Announces Price Target of $280

Li-Metal appoints Anthony Tse as Chairman

Li-Metal launches US$750k equity financing and plans to raise up to US$10M

Li-Metal announces private placement to raise $2 million

Li-Metal enters LOI for sale of lithium metal business

Li-Metal CEO Srini Godavarthy resigns

Arcadium Lithium acquires Li-Metal's lithium metal business

ALTM

LBRMF

Press Releases

Li-Metal Produces Ultra-Thin Lithium on Polymer Anodes Using PVD Technology

Li-Metal Successfully Demonstrates Electrolyte Reconditioning Process for Carbonate-to-Metal Technology

Li-Metal Appoints Anthony Tse as Chairman

Li-Metal Provides Update on Next-Generation Battery Technologies in Partnership with the Ontario Government

Li-Metal Announces Completion of Concept Study for a 1,000-Tonne Commercial-Scale Lithium Metal Plant

Events

Li-Metal to Present at S&P Global's CERAWeek 2024

Li-Metal Wins 2024 Bloomberg New Energy Finance Pioneers Award

Offerings

Li-Metal Announces US$750,000 Equity Financing and Plans to Raise up to US$10.0 Million

Li-Metal Announces Closing of US $750,000 Non-Brokered Private Placement

Commodities

Arcadium Lithium Acquires Li-Metal's Lithium Metal Business to Enhance Production Capabilities and Meet Demand for Next Generation Battery Materials

Li-Metal

Li-Metal Corp&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/LIMFF#OTC">LIMFF</a>) has announced it was granted its first patent by the Canadian Intellectual Property Office (CIPO).

What Happened:&nbsp;Li-Metal has 32 additional patent applications filed.

The CIPO granted all 20 claims Li-Metal made in its patent application related to producing refined lithium metal from a lithium chemical feedstock using an electrowinning apparatus.&nbsp;

Lithium metal is a strategic feedstock material for battery developers and automotive OEMs.&nbsp;

Why It Matters:&nbsp;&ldquo;Receiving this patent further demonstrates our innovation in the production of lithium metal and the broader next-generation battery space. This is an important step in our ongoing efforts to build a deep competitive moat as we position Li-Metal as a leading sustainable and domestic supplier of lithium metal in North America and approach commercialization,&rdquo; said Maciej Jastrzebski, co-founder and CTO of Li-Metal.

About 3,000 tonnes per year of battery-grade lithium metal are produced globally, with more than 90% of that production concentrated in China, according to Benchmark Mineral Intelligence.&nbsp;

By 2030, the demand for lithium metal is projected to increase to over 21,000 tonnes per year. To meet the accelerating domestic demand, Li-Metal continues to work diligently to commercialize its patented lithium metal production technology.

Photo via Company

Li-Metal Corp.&nbsp;(CSE:<a class="ticker" href="https://www.benzinga.com/stock/LIM#CSE">LIM</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/LIMFF#OTCQB">LIMFF</a>), a developer of technologies for electric vehicle batteries, announced on Tuesday that it had entered into an exclusive agreement with&nbsp;Mustang Vacuum Systems, Inc&nbsp;(MVS) to advance its ascent into the production of batteries anodes.

&ldquo;The Partnership supports Li-Metal&rsquo;s growth strategy for its anode business, by securing an experienced machine building partner, thus improving (the) ability to serve its growing customer base,&rdquo; the company said in the release.

The Details

Together, &ldquo;the companies will collaborate exclusively in developing (Physical Vapor Deposition) PVD processes and equipment, and MVS will manufacture PVD equipment exclusively for Li-Metal and Li-Metal&rsquo;s customers in the next-generation battery anode market.

MVP, a specialist in PVD equipment and technologies with nearly 20 years of experience across multiple sectors, will manufacture PVD equipment exclusively for Li-Metal, while protecting the latter&rsquo;s intellectual property.

The two companies agreed to enter a definitive agreement within 28 days. After the definitive agreement is signed, Li-Metal will issue MVS 4,375,000 common shares of Li-Metal and 21,000,000 warrants to purchase common shares of Li-Metal at a price of $0.627.

Li-Metal CEO&nbsp;Maciej Jastrzebski&nbsp;told Benzinga, &ldquo;This exclusive partnership with MVS is a key development for Li-Metal&rsquo;s anode business and our broader vertically integrated growth strategy, as we position ourselves to be a leading battery materials supplier and innovator to the next-generation battery industry. Securing high-performance PVD machine building capability from a proven manufacturer is a big step forward for commercializing our anode technology.&rdquo;

&ldquo;Now, we can leverage large-scale advanced equipment development and manufacturing capabilities to further support current and perspective customers as a reliable, domestic supplier of advanced anode materials technology. Furthermore, we look forward to having MVS as a shareholder, which we believe further strengthens the alignment of this exclusive partnership, as together we work on producing high-performance anode materials to power better EVs and unlock the previously unimaginable in electric transport,&rdquo; he added.

Read Next:&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/news/23/03/31608726/bmw-plans-to-cut-battery-costs-via-recycling-efficient-design-report" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">BMW Plans To Cut Battery Costs Via Recycling, Efficient Design: Report</a>

Toronto-based Li-Metal Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LIMFF#OTC">LIMFF</a>)(CSE:<a class="ticker" href="https://www.benzinga.com/stock/LIM#CSE">LIM</a>),&nbsp;a developer of lithium metal anode and lithium metal technologies,&nbsp;has been approved to trade in the United States on the OTC Pink Market, a U.S. trading platform that is operated by the OTC Markets Group in New York.

The company trades on the OTC Pink under the symbol &ldquo;LIMFF.&rdquo;

&ldquo;Li-Metal&rsquo;s growing presence in the United States, through the commissioning of our U.S. anode production facility, makes our OTC listing and DTC eligibility a natural and important step in our capital markets strategy,&rdquo; said Maciej Jastrzebski, CEO and co-founder of Li-Metal. &ldquo;We are thrilled to be part of trading and settlement platforms that makes it easier for U.S. investors to access and invest in Li-Metal, giving them exposure to the emerging battery materials <a href="https://www.benzinga.com/money/best-sectors-to-invest-in-right-now/">sector</a>.&rdquo;

DTC is a subsidiary of the Depository Trust &amp; Clearing Corporation and manages the electronic clearing and settlement of publicly-traded companies.&nbsp;Having DTC eligibility enables Li-Metal&rsquo;s common shares to be distributed, settled, and serviced through DTC&#39;s automated processes, allowing for a more streamlined trading process in the U.S.

The company&#39;s common shares will continue to trade on the Canadian Securities Exchange under the symbol &ldquo;LIM&rdquo; and on the Frankfurt Stock Exchange under the ticker &ldquo;5Z0.&rdquo;

Photo: Courtesy of&nbsp;<a href="https://www.flickr.com/photos/30478819@N08/" id="yui_3_16_0_1_1648901775101_354944" title="Go to Marco Verch Professional Photographer's photostream">Marco Verch Professional</a>&nbsp;on Flickr

Get Our Top Trade Ideas Delivered Daily - 65% Off Now'

Get Our Top Trade Ideas Delivered Daily - 65% Off Now'

Comments

Li-Metal

News

Latest news for Li-Metal (OTC:LIMFF) Stock

Monday, May 15, 2023

Tuesday, April 04, 2023

Monday, April 04, 2022